News search

Johns Hopkins UniversityBloomberg School of Public HealthBaltimore

Dr. Carla Rothlin is Dorys McConnell Duberg Professor of Immunobiology and Professor of Pharmacology at the Yale School of Medicine, and co-leader of the Cancer Immunology Programme at Yale Cancer Centre. She studied biochemistry and pharmacology at the University of Buenos Aires, where she also undertook her postgraduate research under the direction of Dr. Ana Belén Elgoyhen, focussing on nicotinic receptors expressed in the inner ear. Later, she completed her doctorate and moved to San Diego to join Dr. Greg Lemke’s laboratory at the Salk Institute for Biological Studies. In 2009, Dr. Rothlin was named Assistant Professor in Immunobiology at Yale Medical School

Researchers from the CNIC and Columbia University (USA) review the role of acquired mutations and clonal hematopoiesis in cardiovascular disease

Researchers from the National Center for Cardiovascular Research and the Pompeu Fabra University describe in Science a new mechanism for muscle regeneration after physiological damage

Researchers of IDIBAPS, the University of Barcelona and CNIC describes a new mechanism of innate immunity by which cells fight viruses and bacteria.

Professor Jacob Fog Bentzon from Aarhus University and the CNIC  receives 2 M euros from the European Research Council for a ground-breaking research project on atherosclerosis – one of the most frequent causes of death in the world

Dr. Valentín Fuster will be teaching the summer seminar series “Molecular, Clinical & Population Bases of Cardiovascular Disease and Health”, organized by the  International University Menéndez Pelayo (UIMP) and the Icahn School of Medicine at Mount Sinai.